Topical hemostatic therapy in surgery: bridging the knowledge and practice gap.
暂无分享,去创建一个
L. Kaplan | S. Ozawa | M. Ashton | I. Gross | A. Shander | J. Riley | M. Harris | V. Ferraris | N. Nagarsheth | Jeffrey Nemeth
[1] W. Spotnitz. Hemostats, sealants, and adhesives: a practical guide for the surgeon. , 2012, The American surgeon.
[2] William D Spotnitz,et al. Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox , 2012, Transfusion.
[3] S. Lyman,et al. The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial. , 2012, The Journal of bone and joint surgery. American volume.
[4] S. Muluk,et al. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of anastomotic suture-hole bleeding in expanded polytetrafluoroethylene grafts. , 2012, Journal of vascular surgery.
[5] S. Tafuri,et al. Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty , 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[6] R. Di Micco,et al. Use of Tachosil® in bariatric surgery: preliminary experience in control of bleeding after sleeve gastrectomy. , 2012, Minerva chirurgica.
[7] G. Bianco,et al. Fibrin tissue adhesive reduces postoperative blood loss in total knee arthroplasty , 2012, Journal of Orthopaedics and Traumatology.
[8] T. Tatla,et al. Safety trial of Floseal® haemostatic agent in head and neck surgery , 2012, Annals of the Royal College of Surgeons of England.
[9] T. Kluba,et al. Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty , 2012, Archives of Orthopaedic and Trauma Surgery.
[10] P. Boyer,et al. Does fibrin sealant use in total knee replacement reduce transfusion rates? A non-randomised comparative study. , 2012, Orthopaedics & traumatology, surgery & research : OTSR.
[11] E. Shi,et al. Fibrin sealant provides superior hemostasis for sternotomy compared with bone wax. , 2012, The Annals of thoracic surgery.
[12] P. Austin,et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. , 2012, Archives of surgery.
[13] Sohita Dhillon. Fibrin Sealant (Evicel® [Quixil®/Crosseal™]) , 2011, Drugs.
[14] Masci Emilia,et al. Topical hemostatic agents in surgical practice. , 2011, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[15] N. Singla,et al. Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis. , 2011, Journal of the American College of Surgeons.
[16] A. Kinninmonth,et al. Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray , 2011, Acta orthopaedica.
[17] R. Gamelli,et al. Recombinant human thrombin: safety and immunogenicity in pediatric burn wound excision. , 2011, Journal of pediatric surgery.
[18] C. Wood,et al. A Randomized Trial of Aprotinin-Free Fibrin Sealant Versus Absorbable Hemostat , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[19] S. Burks,et al. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery. , 2011, Annals of vascular surgery.
[20] D. Ubbink,et al. Topical haemostatic agents for skin wounds: a systematic review , 2011, BMC surgery.
[21] D. Manas,et al. Use of Fibrin-Based Sealants and Gelatin-Matrix Hemostats in Laparoscopic Liver Surgery , 2011, Surgical laparoscopy, endoscopy & percutaneous techniques.
[22] Jeffrey Hammond,et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients , 2011, BMC health services research.
[23] J. Massaro,et al. Immune Responses Associated With Perioperative Exposure and Reexposure to Topical Bovine Thrombin Do Not Impair Hemostasis , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[24] N. Heaton,et al. The use of TachoSil in children undergoing liver resection with or without segmental liver transplantation. , 2011, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.
[25] Howard K. Song,et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. , 2011, The Annals of thoracic surgery.
[26] M. Bhandari,et al. Safety and Efficacy of Thrombin-JMI: A Multidisciplinary Expert Group Consensus , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[27] M. Midwinter,et al. Pre-hospital haemostatic dressings: a systematic review. , 2009, Injury.
[28] M. Büchler,et al. Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial. , 2011, Surgery.
[29] I. Chetter,et al. Randomized clinical trial of tranexamic acid‐free fibrin sealant during vascular surgical procedures , 2010, The British journal of surgery.
[30] S. Burks,et al. State-of-the-Art Review: Hemostats, Sealants, and Adhesives II: Update As Well As How and When to Use the Components of the Surgical Toolbox , 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[31] H. Achneck,et al. Application Of Energy-based Technologies And Topical Hemostatic Agents In The Management Of Surgical Hemostasis , 2010, Vascular.
[32] C. Sundaram,et al. Evolution of hemostatic agents in surgical practice , 2010, Indian journal of urology : IJU : journal of the Urological Society of India.
[33] C. Vicentini,et al. World Journal of Surgical Oncology Open Access Technical Innovations Haemostatics in Surgery and Our Experience in the Enucleoresection of Renal Cell Carcinoma , 2022 .
[34] R. Ciria,et al. A prospective study of the efficacy of clinical application of a new carrier-bound fibrin sealant after liver resection. , 2010, Archives of surgery.
[35] Bantayehu Sileshi,et al. A Comprehensive Review of Topical Hemostatic Agents: Efficacy and Recommendations for Use , 2010, Annals of surgery.
[36] M. Reynolds,et al. Topical bovine thrombin: a 21‐year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System , 2010, Pharmacoepidemiology and drug safety.
[37] W. Chapman,et al. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin. , 2010, Journal of the American College of Surgeons.
[38] M. Giordano,et al. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study , 2010, Acta Neurochirurgica.
[39] F. Pecoraro,et al. Efficacy of TachoSil® patches in controlling Dacron suture-hole bleeding after abdominal aortic aneurysm open repair , 2009, Journal of cardiothoracic surgery.
[40] F. Bartolomucci,et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. , 2009, The Annals of thoracic surgery.
[41] J. Ikonomidis,et al. Topical thrombin preparations and their use in cardiac surgery , 2009 .
[42] M. Dubick,et al. Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine. , 2009, The Journal of trauma.
[43] G. Moneta,et al. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis. , 2009, Journal of the American College of Surgeons.
[44] B. A. Boucher,et al. Achieving Hemostasis in the Surgical Field , 2009, Pharmacotherapy.
[45] O. Traub,et al. Topical Thrombins: Benefits and Risks , 2009, Pharmacotherapy.
[46] F. Bonilla-musoles,et al. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. , 2009, Fertility and sterility.
[47] Andrea Frilling,et al. Efficacy of TachoSil a fibrin-based haemostat in different fields of surgery- a systematic review , 2009, Expert opinion on biological therapy.
[48] G. Rodgers,et al. Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety , 2009, Patient safety in surgery.
[49] T. Ortel,et al. Recent developments in topical thrombins , 2009, Thrombosis and Haemostasis.
[50] F. Logoluso,et al. The effectiveness of FloSeal® matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study , 2009, Langenbeck's Archives of Surgery.
[51] R. Gamelli,et al. Recombinant Thrombin: Safety and Immunogenicity in Burn Wound Excision and Grafting , 2009, Journal of burn care & research : official publication of the American Burn Association.
[52] R. Angioli,et al. Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma. , 2009, Journal of minimally invasive gynecology.
[53] A. Tailor,et al. Intraoperative haemostasis with new fibrin surgical sealant (Quixil®) in gynaecological oncology , 2009, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[54] Wesley K. Lew,et al. Clinical use of topical thrombin as a surgical hemostat , 2008, Biologics : targets & therapy.
[55] S. Burks,et al. Hemostats, sealants, and adhesives: components of the surgical toolbox , 2008, Transfusion.
[56] Wesley K. Lew,et al. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures. , 2008, Journal of vascular surgery.
[57] C. Wood,et al. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery* , 2008, Current medical research and opinion.
[58] M. Reynolds,et al. Topical bovine thrombin and adverse events: a review of the literature. , 2008, Current medical research and opinion.
[59] Jens-Uwe Stolzenburg,et al. Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study. , 2007, European urology.
[60] D. Gurushanthaiah,et al. Prospective, Randomized, Controlled Trial of a Hemostatic Sealant in Children Undergoing Adenotonsillectomy , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[61] J. Lam,et al. Use of haemostatic agents and glues during laparoscopic partial nephrectomy: a multi-institutional survey from the United States and Europe of 1347 cases. , 2007, European urology.
[62] W. Chapman,et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. , 2007, Journal of the American College of Surgeons.
[63] J. Lowe,et al. Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study. , 2007, The Journal of cardiovascular surgery.
[64] D. Beverland,et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. , 2007, The Journal of bone and joint surgery. British volume.
[65] D. Sindram,et al. The balance of thrombosis and hemorrhage in surgery. , 2007, Hematology/oncology clinics of North America.
[66] O. Durrani,et al. Use of a Novel Topical Hemostatic Sealant in Lacrimal Surgery: A Prospective, Comparative Study , 2007, Ophthalmic plastic and reconstructive surgery.
[67] W. Chapman,et al. Phase 2, randomized, double‐blind, placebo‐controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications , 2006, Journal of thrombosis and haemostasis : JTH.
[68] Andrew D. Rosenberg,et al. Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies , 2006 .
[69] G. Torelli,et al. Pathophysiology of bleeding in surgery. , 2006, Transplantation proceedings.
[70] O. Nativ,et al. Sutureless nephron-sparing surgery: use of albumin glutaraldehyde tissue adhesive (BioGlue). , 2006, Urology.
[71] M. Jameson,et al. FloSeal use in endoscopic sinus surgery: effect on postoperative bleeding and synechiae formation. , 2006, American journal of otolaryngology.
[72] C. Thompson,et al. Tissue Adhesives: A Review , 2006 .
[73] Jack P. C. Kleijnen,et al. State-of-the-Art Review: A User's Guide to the Brave New World of Designing Simulation Experiments , 2005, INFORMS J. Comput..
[74] H. Mischinger,et al. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial , 2005, Langenbeck's Archives of Surgery.
[75] M.Med.Sci. Martin P. Sintler FRCS,et al. Randomized Trial Comparing Quixil Surgical Sealant with Kaltostat Hemostatic Dressing to Control Suture Line Bleeding after Carotid Endarterectomy with ePTFE Patch Reconstruction , 2005, World Journal of Surgery.
[76] R. Cruz,et al. Prospective, Randomized, Controlled Clinical Trial of a Novel Matrix Hemostatic Sealant in Children Undergoing Adenoidectomy , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[77] N. Heaton,et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. , 2004, Archives of surgery.
[78] J. Block,et al. Improved Intraoperative Management of Anastomotic Bleeding during Aortic Reconstruction: Results of a Randomized Controlled Trial , 2004, The American surgeon.
[79] T. Scalea,et al. The combination of platelet-enriched autologous plasma with bovine collagen and thrombin decreases the need for multiple blood transfusions in trauma patients with retroperitoneal bleeding. , 2004, The Journal of trauma.
[80] Atilla Aral,et al. Comparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery. , 2003, The Journal of thoracic and cardiovascular surgery.
[81] S. Gundry,et al. Prospective randomized study of a protein-based tissue adhesive used as a hemostatic and structural adjunct in cardiac and vascular anastomotic repair procedures. , 2003, Journal of the American College of Surgeons.
[82] D. M. Anthony,et al. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. , 2003, The Cochrane database of systematic reviews.
[83] W. Chapman,et al. Effective Management of Bleeding during Tumor Resection with a Collagen-Based Hemostatic Agent , 2002, The American surgeon.
[84] M. Codispoti,et al. Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[85] D. M. Anthony,et al. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion , 2002, The British journal of surgery.
[86] L. Messina,et al. Gelatin–thrombin-based Hemostatic Sealant for Intraoperative Bleeding in Vascular Surgery , 2002, Annals of vascular surgery.
[87] A. Gheissari,et al. A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin: results of a randomized controlled trial. , 2002, Archives of surgery.
[88] Howard S. An,et al. A Multicenter, Prospective, Randomized Trial Evaluating a New Hemostatic Agent for Spinal Surgery , 2001, Spine.
[89] William C. Chapman,et al. A novel collagen-based composite offers effective hemostasis for multiple surgical indications: Results of a randomized controlled trial. , 2001, Surgery.
[90] P. A. Nelson,et al. Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma. , 2001, Journal of biomedical materials research.
[91] G. Buncke,et al. Costasis® Provides Superior Control of Diffuse Bleeding at Muscle-Flap Donor Sites, Compared to Manual Compression , 2000, Journal of reconstructive microsurgery.
[92] W. Chapman,et al. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. , 2000, Archives of surgery.
[93] M. Oz,et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery , 2000 .
[94] M. Oz,et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. , 2000, The Annals of thoracic surgery.
[95] R. Gamelli,et al. Multicenter trial to evaluate the safety and potential efficacy of pooled human fibrin sealant for the treatment of burn wounds. , 1999, The Journal of trauma.
[96] N. Starr,et al. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery* , 1998, Critical care medicine.
[97] R. Gamelli,et al. Use of fibrin sealant in thermal injury. , 1997, The Journal of burn care & rehabilitation.
[98] R. Bartlett,et al. Prospective, randomized evaluation of the efficacy of fibrin sealant as a topical hemostatic agent at the cannulation site in neonates undergoing extracorporeal membrane oxygenation. , 1997, American journal of surgery.
[99] J Hagmann,et al. Tactical combat casualty care in special operations. , 1996, Military medicine.
[100] W. G. Murphy,et al. A Randomised Trial of Fibrin Sealant in Peripheral Vascular Surgery , 1996, Vox sanguinis.
[101] C. V. Ruckley,et al. Fibrin sealant reduces suture line bleeding during carotid endarterectomy: a randomised trial. , 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[102] S. Miller,et al. The hemostatic effect of fibrin glue on graft donor sites. , 1994, The Journal of burn care & rehabilitation.
[103] D. Cosgrove,et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. , 1989, The Journal of thoracic and cardiovascular surgery.
[104] S. D. Bustros,et al. The use of intravitreal thrombin to control hemorrhage during vitrectomy. , 1986, Ophthalmology.
[105] P. Dineen. Antibacterial activity of oxidized regenerated cellulose. , 1976, Surgery, gynecology & obstetrics.